Old CIC Events
13/06/2019
MEK5 as a driver in lung cancer
Adrián Sánchez Fernández — Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca
06/06/2019
Regnase-1, a key endoribonuclease responsible for the inflammatory and immune responses
Shizuo Akira — Laboratory of Host Defense, WPI Immunology Frontier Research Center, and Department of Host Defense, Research Institute for Microbial Diseases, University of Osaka [Osaka, Japan]
30/05/2019
KRAS driven lung adenocarcinoma depends on ERBB signaling
Emilio Casanova-Hevia — Ludwig Boltzmann Institute Cancer Research [Vienna, Austria]
16/05/2019
Cell-of-origin of prostate cancer and clinical heterogeneity
Esther Baena Chaparro — Cancer Research UK Manchester Institute [Manchester, UK]
09/05/2019
CLINICAL IMPACT OF DNA REPAIR DEFECTS IN PROSTATE CANCER
Elena Castro Marcos — Spanish National Cancer Research Centre (CNIO)
06/05/2019
Host-Microbiota Interactions in Health and Disease
Gabriel Núñez — University of Michigan [Michigan, USA]
02/05/2019
Novel targeted therapies in lymphoid neoplasia: from apoptosis activation to microenvironment harnessing
Patricia Pérez Galán — IDIBAPS- Hospital Clinic, Barcelona
25/04/2019
MHC CLASS I LOSS AND CANCER IMMUNE ESCAPE
Federico Garrido — Universidad de Granada [Granada, Spain]
11/04/2019
CCR EN EL ADULTO JOVEN, UNA ENTIDAD DIFERENTE
Jessica Pérez García — Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca
04/04/2019
Inmunoterapia de síndromes linfoproliferativos y enfermedad de injerto contra huésped con anticuerpos contra el receptor de quimiocinas CCR7.
Cecilia Muñoz Calleja — Instituto de Investigación Sanitaria Hospital Universitario de La Princesa [Madrid, Spain]
28/03/2019
How can 3D structure knowledge help systems biology?
Baldo Oliva Miguel — Universidad Pompeu Fabra (UPF) [Barcelona]